[Cystitis treatment with immunoactive Escherichia coli fractions].
Conrad
S
S
Urologische Klinik und Poliklinik der Universität, Hamburg.
Huland
H
H
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000627:therapeutic use*; D003556:Cystitis / Q000628:therapy*; D004343:Drug Implants; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000628:therapy*; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active / Q000009:adverse effects; D007422:Intestines / Q000382:microbiology; D012008:Recurrence
D000276:Adjuvants, Immunologic; D000892:Anti-Infective Agents, Urinary; D004343:Drug Implants
Cystitistherapie mit immunaktiven Escherichia coli-Fraktionen.